BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• 

  Patents

  Delaware Judge Throws Out Pfizer’s $107.5M Tagrisso Patent Win Over AstraZeneca

  Just months after a jury ordered payment to Pfizer in the patent infringement case, a Delaware judge has nullified the award and invalidated the patents behind the lawsuit involving AstraZeneca’s blockbuster lung cancer drug.

  August 16, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Editorial

  Medicare Negotiated Drug Prices Are Hollow Victory for Biden, Harris

  For the Biden-Harris administration to compare the newly announced negotiated Medicare prices to the list prices for these drugs is, at best, not very meaningful. At worst, it’s disingenuous.

  August 16, 2024

   · 

  5 min read

   · 

  Greg Slabodkin
• 

  Layoffs

  Lykos to Slash 75% of Workforce Following FDA Rejection

  Lykos will lay off approximately three-quarters of its staff amidst a reorganization aimed at helping the company complete a regulatory resubmission for its MDMA-assisted therapy.

  August 16, 2024

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Infectious disease

  Pfizer, BioNTech’s Mixed Phase III Data Sets Back COVID-Flu Vaccine Candidate

  The companies’ late-stage stumble could allow Moderna to widen its lead, with its mRNA-based combination vaccine eliciting superior immune responses against COVID-19 and three influenza strains.

  August 16, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Vaccines

  Bavarian Nordic Sees Potential Windfall Opportunity Amid Global Mpox Emergency

  The company can make 10 million doses available next year, with $600 million to $1 billion in revenue potential into 2025, “albeit perhaps lower on price, discounts and donations,” according to Jefferies analyst Peter Welford.

  August 16, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Regulatory

  AstraZeneca’s Imfinzi Scores Lung Cancer Wins With FDA’s NSCLC Approval, SCLC Priority Review

  Imfinzi’s perioperative approval comes after both the FDA’s staffers and a panel of external experts expressed concerns about overtreatment when using the PD-L1 blocker both before and after surgery.

  August 16, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• Business

  Lifeward Reports Second Quarter 2024 Financial Results

  August 16, 2024

   · 

  17 min read
• Press Releases

  Children’s Hospital of Philadelphia Researchers Reveal New Hope for Chemotherapy-Resistant Neuroblastoma Patients

  August 16, 2024

   · 

  5 min read
• Press Releases

  CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event

  August 16, 2024

   · 

  1 min read
• Press Releases

  FDA Issues Warning Letter to Austrofood and Continues Robust Activities to Ensure Safety of Cinnamon Products Sold in U.S.

  August 16, 2024

   · 

  7 min read